BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23788983)

  • 1. UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study.
    Dodurga Y; Avcı CB; Yılmaz S; Nazlı O; Coğulu O; Cankaya T; Gündüz C
    Contemp Oncol (Pozn); 2013; 17(2):156-60. PubMed ID: 23788983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
    Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
    Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit).
    Bravaccini S
    Methods Mol Biol; 2021; 2292():35-48. PubMed ID: 33651350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer detection using FISH (UroVysion assay).
    Halling KC; Kipp BR
    Adv Anat Pathol; 2008 Sep; 15(5):279-86. PubMed ID: 18724101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients.
    Nagai T; Okamura T; Yanase T; Chaya R; Moritoki Y; Kobayashi D; Akita H; Yasui T
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1271-1273. PubMed ID: 31030505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation.
    Dimashkieh H; Wolff DJ; Smith TM; Houser PM; Nietert PJ; Yang J
    Cancer Cytopathol; 2013 Oct; 121(10):591-7. PubMed ID: 23801650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.
    Bonberg N; Taeger D; Gawrych K; Johnen G; Banek S; Schwentner C; Sievert KD; Wellhäußer H; Kluckert M; Leng G; Nasterlack M; Stenzl A; Behrens T; Brüning T; Pesch B;
    BJU Int; 2013 Aug; 112(4):E372-82. PubMed ID: 23350736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
    Bergman J; Reznichek RC; Rajfer J
    BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.
    Riesz P; Lotz G; Páska C; Szendrôi A; Majoros A; Németh Z; Törzsök P; Szarvas T; Kovalszky I; Schaff Z; Romics I; Kiss A
    Pathol Oncol Res; 2007; 13(3):187-94. PubMed ID: 17922047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
    Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS
    J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
    Halling KC; King W; Sokolova IA; Karnes RJ; Meyer RG; Powell EL; Sebo TJ; Cheville JC; Clayton AC; Krajnik KL; Ebert TA; Nelson RE; Burkhardt HM; Ramakumar S; Stewart CS; Pankratz VS; Lieber MM; Blute ML; Zincke H; Seelig SA; Jenkins RB; O'Kane DJ
    J Urol; 2002 May; 167(5):2001-6. PubMed ID: 11956427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology.
    Placer J; Espinet B; Salido M; Solé F; Gelabert-Mas A
    Eur Urol; 2002 Dec; 42(6):547-52. PubMed ID: 12477649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer.
    Varella-Garcia M; Akduman B; Sunpaweravong P; Di Maria MV; Crawford ED
    Urol Oncol; 2004; 22(1):16-9. PubMed ID: 14969798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer.
    Karnwal A; Venegas R; Shuch B; Bassett J; Rajfer J; Reznichek R
    Can J Urol; 2010 Apr; 17(2):5077-81. PubMed ID: 20398445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer.
    Junker K; Fritsch T; Hartmann A; Schulze W; Schubert J
    Cytogenet Genome Res; 2006; 114(3-4):279-83. PubMed ID: 16954667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
    Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
    Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis.
    Wild PJ; Fuchs T; Stoehr R; Zimmermann D; Frigerio S; Padberg B; Steiner I; Zwarthoff EC; Burger M; Denzinger S; Hofstaedter F; Kristiansen G; Hermanns T; Seifert HH; Provenzano M; Sulser T; Roth V; Buhmann JM; Moch H; Hartmann A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1798-806. PubMed ID: 19454613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.
    Bubendorf L; Grilli B; Sauter G; Mihatsch MJ; Gasser TC; Dalquen P
    Am J Clin Pathol; 2001 Jul; 116(1):79-86. PubMed ID: 11447756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.